Conatus, ViaCyte, Organovo, and More
Summary
—A San Diego startup, Pediatric Bioscience, is developing a diagnostic test for a certain combination of maternal biomarkers that have been linked to autism spectrum disorders.A study led by Judy Van de Water, an immunologist at the UC Davis School of Medicine, found that 23 percent of children with autism spectrum disorders have mothers with a specific combination of auto antibodies.—The share price of San Diego-based Organovo (NYSE: ONVO) increased by more than a third as the company said it was shifting its listing to the New York Stock Exchange from the over-the-counter market.—After forging a partnership with Bristol-Myers Squibb (NYSE: BMY) in April, the Danish biopharmaceutical Santaris Pharma said it signed an agreement with Cambridge, MA-based RaNA Therapeutics.Santaris, which has R&D operations in San Diego, agreed to provide its Locked Nucleic Acid (LNA) technology to help RaNa develop RNA-targeted medicines.